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Abstract
Background: Annually, some 9000 people in Switzerland suffer a first time stroke. Of these 60% are left with
moderate to severe walking disability. Evidence shows that rehabilitation techniques which emphasise activity of
the hemiplegic side increase ipsilesional cortical plasticity and improve functional outcomes. Canes are commonly
used in gait rehabilitation although they significantly reduce hemiplegic muscle activity. We have shown that an
orthosis “TheraTogs” (a corset with elasticated strapping) significantly increases hemiplegic muscle activity during
gait. The aim of the present study is to investigate the long term effects on the recovery of gait, balance and
social participation of gait rehabilitation with TheraTogs compared to gait rehabilitation with a cane following first
time acute stroke.
Methods/Design: Multi-centre, single blind, randomised trial with 120 patients after first stroke. When subjects
have reached Functional Ambulation Category 3 they will be randomly allocated into TheraTogs or cane group.
TheraTogs will be applied to support hip extensor and abductor musculature according to a standardised
procedure. Cane walking held at the level of the radial styloid of the sound wrist. Subjects will walk throughout
the day with only the assigned walking aid. Standard therapy treatments and usual care will remain unchanged
and documented. The intervention will continue for five weeks or until patients have reached Functional
Ambulation category 5. Outcome measures will be assessed the day before begin of intervention, the day after
completion, 3 months, 6 months and 2 years. Primary outcome: Timed “up and go” test, secondary outcomes: peak
surface EMG of gluteus maximus and gluteus medius, activation patterns of hemiplegic leg musculature, temporo-
spatial gait parameters, hemiplegic hip kinematics in the frontal and sagittal planes, dynamic balance, daily activity
measured by accelerometry, Stroke Impact Scale. Significance levels will be 5% with 95% CI’s. IntentionToTreat
analyses will be performed. Descriptive statistics will be presented.
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Discussion: This study could have significant implications for the clinical practice of gait rehabilitation after stroke,
particularly the effect and appropriate use of walking aids.
The results could be important for the development of clinical guidelines and for the socio-economic costs of
post-stroke care
Trial registration number: ClinicalTrials.gov NCT01366729.
Background - presentation of the hypothesis
Stroke is the leading cause of acquired disability in
adults [1]. In Switzerland approximately 9000 people a
year suffer a first time stroke [2]. Of those patients who
survive the acute phase, between 20 and 30% are unable
to walk [3]. Those who can are often left with moderate
to severe walking disability and reduced gait speeds
[3,4]. The risk of falling increases–a recent study indi-
cating that at 3 months 28% of stroke patients have
fallen [5]. The resulting disability has an enormous
socioeconomic impact on patients, families and health
service providers [6,7].
Rehabilitation methods which improve balance and
gait are crucial for the quality of life of stroke victims
and to reduce the ongoing cost of long term care. Stu-
dies have shown that early rehabilitation in specialised
settings e.g. stroke units results in better functional out-
come than in non-specialised units [8,9]. It has been
suggested that these better results are achieved partly
due to enhanced staff awareness of the importance of
mobility thus preventing secondary complications such
as loss of cardiovascular fitness or muscle weakness.
The physical environment is also likely to be adapted
enabling more independent movement [10,11]. Current
rehabilitation methods which aim to improve motor
control during walking do not appear to deliver addi-
tional improvements [12,13]. A recent meta-analysis
showed that only cardiorespiratory physical fitness train-
ing provides robust evidence for a benefit to walking
ability after stroke. Repetitive task training also appeared
to have some effect. Motor and neurophysiological
approaches did not demonstrate a positive effect on
walking recovery [13]. This suggests that underlying
mechanisms responsible for the recovery of motor co-
ordination and control of walking following stroke are
not significantly influenced by current therapy methods.
These findings are further illustrated by studies which
show that long term improvements in gait function
occur in the absence of improvements in muscle co-
ordination patterns [14] or improved kinematic or
kinetic gait profiles [15]. Buurke et al. [14] concluded
that “functional gait improvements may be more related
to compensatory strategies than by restitution of muscle
co-ordination patterns in the affected leg.” Kautz et al.
[16] concluded that “There is no evidence of improved
locomotor co-ordination post intervention. The
increased walking and pedalling speed were achieved by
a more proficient use of the same impaired pattern
without EMG timing changes, likely because of
increased strength and endurance post intervention.”
We suggest that improvements in gait function due to
current rehabilitation methods are predominantly
achieved through more efficient use of abnormal move-
ment patterns. This may be a reason for the generally
low level of independence and function achieved follow-
ing stroke.
Spontaneous recovery which occurs within the first
weeks post stroke largely defines long term functional
outcome [17]. Recent studies investigating changes in
the cerebral cortex following focal injury have indicated
that cortical plasticity and neuronal growth that occurs
early after infarct may “underlie the brain’s self-repair
process” [18,19]. Evidence shows that this early cortical
plasticity is an important factor in the spontaneous
recovery of motor control which predicts long term out-
come [18-22]. We suggest that it is this process which is
inadequately influenced by current rehabilitation meth-
ods. The recovery of motor skills following stroke relies
on the brains ability to reorganise its neuronal control
of movement [19,20]. Reorganisation can occur within
and between cortical networks both within the lesioned
and non-lesioned hemisphere [18,21]. Rossini et al. sta-
ted that “Reorganization phenomena following ischemic
stroke observed so far, may be classified into two main
groups: overactivation of areas belonging to the neural
network for a specific task–or activation of unusual
areas that attempt to replace the function of the
damaged tissue” [18]. The overactivation of the original
neural network is primarily activity in the lesioned
hemisphere. Following stroke cortical activity has been
recorded in both lesioned and non-lesioned hemispheres
during movement [21,23]. Increasingly findings show
that increased activity in the lesioned hemisphere corre-
lates with better recovery and improved motor perfor-
mance [23-27]. Conversely increased activity in the
contralesional hemisphere is associated with poorer
motor recovery of the hemiplegic limb [26,27]. It
appears that improved motor recovery occurs when the
brain is able to make use of the original neural network
to control movement. When new networks are formed
for example in the unaffected hemisphere, motor recov-
ery is reduced. The authors suggest that activity in the
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original network represents “true” recovery. The recruit-
ment of new networks may represent the learning of
compensatory movement strategies associated with
poorer functional outcome.
Findings in favour of this hypothesis have been
demonstrated in both upper and lower limbs [25-27].
As post-injury behavioural experience is critical to the
reassembly of adaptive networks and strongly influ-
ences cortical reorganisation [22,28] these results indi-
cate that treatment approaches which promote
increased plasticity in the lesioned hemisphere will
promote greater functional recovery. This assumption
is supported by a recent meta-analysis [21] which
examined whether participating in stroke rehabilitation
which emphasised use of the paretic upper limb was
associated with increased cortical activity of the
lesioned hemisphere and consequently better function.
The review concluded that neural changes in the sen-
sorimotor cortex of the lesioned hemisphere were
achieved with rehabilitation interventions that empha-
sized use of the paretic upper limb and resulted in
improved functional motor gains.
Nudo et al. [28] demonstrated with squirrel monkeys
that forced retraining of skilled hand use prevented loss
of hand territory representation adjacent to the infarct
and in some instances the representations expanded.
This functional reorganization was accompanied by
recovery of skilled hand movements. Control monkeys
with identical lesions who did not receive therapy lost
paretic hand representation und function.
In general these results suggest that therapies which
emphasise use of the hemiplegic side promote plasticity
in the lesioned hemisphere through emphasising the use
of previously established neural networks and are asso-
ciated with improved function. It may be that therapies
which promote compensatory movement or reduce
activity of the hemiplegic limb inhibit plasticity in the
lesioned hemisphere and promote the development of
new neural networks associated with reduced function.
To date therapies which emphasise use of the hemi-
plegic limb have been confined to the upper extremity
[29,30] and have not been applied during gait rehabilita-
tion following stroke. Canes are very commonly used
post stroke although studies have consistently shown a
significant reduction in surface electromyography
(EMG) activity in all muscle groups on the side contral-
ateral to cane use in both stroke and non-stroke patients
[14,31-33]. In light of the factors which increase plastic
reorganisation in the lesioned hemisphere, namely inter-
ventions which emphasise use of the paretic limb, the
effect of canes which reduce activity in the hemiplegic
side may be to inhibit activity in the original neural net-
works responsible for lower limb control resulting in
poorer walking function.
In gait rehabilitation, attention should also be paid to
the optimal restoration of balance. In relation to bal-
ance, evidence shows that balance control does not
occur automatically at spinal cord and brainstem level
as has previously been thought, but rather is highly
influenced by cortical activity and cognitive control
[34-36]. Two main types of balance strategies are recog-
nised–fixed support or change of support strategies
[34,35]. Fixed support strategies are used when no step-
ping or reaching activities are needed to maintain bal-
ance. Rotatory torques are generated through muscle
activity primarily around the hip and ankle. Change of
support strategies are used in challenging conditions
when stepping or reaching reactions are necessary to
maintain equilibrium. Fixed support strategies use less
cognitive resources than change in support [34,35].
Elderly people or subjects with poor balance use more
change in support strategies and therefore more cogni-
tive resources than younger, healthy subjects to main-
tain equilibrium under the same conditions.
The authors suggest that balance rehabilitation should
attempt to restore balance strategies used by healthy
individuals–namely fixed support responses requiring
fewer cognitive resources in unchallenging situations.
However cane use increases the base of support when
walking through use of the arms. This strategy may
emphasise use of cortical networks used for reaching
“change of support” reactions. It emphasises use of cog-
nitive resources on safe level ground and reduces the
use of “fixed support” strategies. The authors suggest
this leads to a long term reduction of automatic balance
responses. It may be that because cognitive resources
are needed in safe, level environments fewer additional
resources are available for more difficult conditions such
as walking outside or on public transport. The long
term effects of canes on balance recovery and functional
gait following stroke has to our knowledge been investi-
gated in one study [37]. Balance recovery and commu-
nity participation were shown to be reduced.
Taking all of these considerations together, the
authors suggest that an optimal walking aid for post
stroke gait rehabilitation would provide enough support
to enable independent early walking without reducing
hemiplegic muscle activity or inhibiting the use of bal-
ance reactions. The immediate effect of an elasticised
orthotic walking aid (TheraTogs) on hemiplegic hip
abductor activity has been previously investigated by the
authors [38]. Activity in gluteus medius was increased
by 16.5% compared to walking without aids when walk-
ing with TheraTogs (with cane use activity in gluteus
medius was reduced by 22% compared to walking with-
out aids). The increased activity with TheraTogs may be
due to increased proprioceptive input provided by the
orthosis or to the physical shortening of the muscle
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leading to increased overlap between the actin and myo-
sin filaments and consequently a stronger contraction.
The authors hypothesize that cane use will inhibit
activity on the hemiplegic side leading to reduced ipsile-
sional cortical activity and poorer long term functional
gait outcomes. In contrast we hypothesize that Thera-
Togs will increase activity on the hemiplegic side during
walking leading to increased ipsilesional cortical activity
and improved long term functional gait outcomes.
We further hypothesize that cane use will inhibit the
use of normal balance reactions leading to reduced bal-
ance recovery and poorer social participation. As no
external support is provided with the TheraTogs ortho-
sis the use of automatic balance responses will not be
inhibited during walking. This will result in improved
balance recovery and social participation.
The aim of this study is to investigate the long term
effects of canes and TheraTogs on the recovery of
motor control and co-ordination, gait, daily activity, bal-
ance and social participation when used in early gait
rehabilitation following stroke.
Methods - testing the hypothesis
Design and setting
This study is a multi-centred single blind, randomised,
control trial with parallel design.
Subjects will be recruited from the neurological reha-
bilitation department of 3 participating Swiss hospitals:
Felix Platter Spital Basel, Kantonspital Luzern Neuroreh-
abiltaton and Reha Clinic Zurzach. Each department is a
dedicated unit specialising in the rehabilitation of post
acute neurological patients. Ethical approval has been
obtained from the following cantonal ethics committees:
Basel (Ethikkommission Beider Basel), Luzern (Ethik-
kommission Kanton Luzern), Aargau (Ethikkommission
Kanton Aargau).
In- and exclusion criteria
All subjects (1) will be patients with hemiplegia follow-
ing a first unilateral stroke, (2) will score at least level 3
on the Functional Ambulation Category (FAC) [39]
(able to walk unaided on even ground but requiring ver-
bal prompts and stand-by help without body contact)
and (3) must have been independent walkers prior to
insult without walking aids. (4) Subjects will have a
Mini Mental State [40] score of 22 or above, (5) will
have no orthopaedic or other neurological conditions
that could limit walking ability, (6) have no gross visuos-
patial or visual field deficits and (7) will have no medical
contraindications to walking.
Recruitment
Potential subjects will be identified by rehabilitation staff
at the participating hospitals. Suitability for participation
will be checked and confirmed by the researchers.
Signed, informed consent will be obtained from subjects
before inclusion and randomisation. Subjects will be
randomised into TheraTogs (intervention) and cane
(control) group (see below). Intervention will begin
when patients have reached level 3 on the FAC.
Intervention details
Interventions will be applied for five weeks. If patients
become independent walkers before this time (FAC 5)
the intervention will be discontinued. If patients are
discharged before this time and have not reached FAC
5 where possible the home carer will be instructed in
the application of TheraTogs and the intervention will
continue for 5 weeks as planned. TheraTogs will be
applied as part of the washing/dressing routine in the
morning by therapists or nursing staff instructed in the
standard application. Subjects will walk throughout the
day until preparing for bed with the prescribed walking
aid. Standby assistance only will be provided during
walking when necessary for safety. No other form of
walking aid will be used for the duration of the study
intervention. Foot or foot/ankle orthoses will remain
unchanged and be worn as usual. All other forms of
therapy (frequency and type) will remain unchanged
and documented. Patients will receive usual care.
When therapists feel that TheraTogs hinders treatment
sessions the application may be removed for the dura-
tion of the session. It must be immediately reapplied
with the standard application following treatment.
When necessary TheraTogs may be removed for sleep-
ing in the afternoon. It will be reapplied with the stan-
dard application on waking.
TheraTogs is worn directly on the skin. Attached to
the basic suit hip abductor support [38] will consist of
two broad straps attached 1.to the anterior torso,
pulled downwards across the abductors towards and
attached to the posterior aspect of the hemiplegic leg
and, 2. to the posterior aspect of the torso pulled
downwards to cross the abductors and attach to the
anterior aspect of the hemiplegic leg. For hip extension
one wide strap will be attached to the top of the pelvic
rim on the non-hemiplegic side, pulled downwards and
laterally passing across the buttock and towards the
anterior aspect of the hemiplegic thigh attaching later-
ally (Figure 1.). Standard application training sessions
will be provided to all staff before study begin. Written
and photographic instructions will be provided. Thera-
Togs suits will be marked to ensure consistent
application.
In the control group cane walking will take place with
cane held at the level of the radial styloid of the sound
wrist. Occurrences of non-adherence to the protocol
will be documented in subject notebooks.
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Measures
Outcome measures will be taken at baseline, defined as
the day before intervention begin, the day after interven-
tion is completed (max. 5 weeks), 3 months, 6 months
and 2 years after intervention begin.
Baseline descriptives
At baseline descriptive variables for each patient includ-
ing age, sex area and type of infarct, side of stroke, time
since stroke, height and weight will be recorded.
Primary outcome
The primary outcome measure will be the time taken to
complete the Timed “Up and Go” Test [41]. This is a
basic test for functional mobility which has good relia-
bility and validity [41,42]. The seat height will be 65% of
the subjects leg length and subjects will turn towards
the unaffected side [43].
Secondary outcomes
The following secondary outcomes will be measured
during walking and during sit to stand (in “Timed up
and go”):
Peak surface EMG measurement of gluteus maximus
and gluteus medius muscle (TMS International,
Enschede, Holland);
Activation patterns of gluteus maximus, gluteus med-
ius, vastus lateralis, semitendinosis, gastrocnemius and
tibialis anterior;the peak SEMG amplitude of the maxi-
mum voluntary contraction of the unaffected gluteus
maximus and medius will also be measured.
Temperospatial gait parameters–gait speed, cadence,
step length, stride length, stance phase and swing phase
of both legs; hip kinematics in the frontal and sagittal
planes using twin-axis electrogoniometers (Biometrics
Ltd UK, USA SG 150).
An intergrated system The Porti-system with a Poly-
bench software package (TMS International, Enschede,
Holland) will be used to simultaneously measure these
parameters together with a synchronised camcorder
with a sagittal view.
Dynamic balance will be simultaneously measured
using two angular velocity sensors (fibreoptic gyro-
scopes) of the SwayStar balance system (Balance Inter-
national Innovations GmbH, Iseltwald, Switzerland)
[44,45].
Muscle strength of hemiplegic and non-hemiplegic hip
abductors will be measured using a hand held
dynamometer.
Daily activity during the intervention will be measured
using an accelerometer (Aipermon GmbH, Germany).
Activity modes and accelerometer detection accuracy
have been validated [46].
Social participation will be measured using The Stroke
Impact Scale (SIS) [47]. Validated German, French and
Italian versions will be used [47,48]. The Stroke Impact
Scale is a stroke specific evaluative instrument that mea-
sures the impact of stroke in multiple domains including
physical, emotional, memory/thinking, communication
and social participation. It is a face-to-face interviewer
administered instrument that takes 15 to 20 min to con-
duct [47].
“Usual care” will be documented daily for each patient
in a specifically designed questionnaire. Each 10 min
treatment block will be classified into 1 of 5 categories.
(See attachment “Documentation Standard Therapy.”).
Technical details about the measurement of primary
and secondary outcome variables are explained below.
Testing procedure
Physical measurements take place and data collection is
performed in a specific, standardised order, conform to
the following protocol:
1. Hip abductor muscle strength on both sides of the
body will be measured using a hand-held dynam-
ometer. Each test will be performed three times for
each leg starting with the healthy leg then alternat-
ing. Subjects will rest for 30 sec between trials. Sub-
jects will lie in supine on an examination plinth.
Figure 1 Standard Application TheraTogs.
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Two Velcro straps will be applied to stabilise the
pelvis (applied over both anterior superior iliac
spines and attached to the bed) and the thorax/spine
(applied to the chest below the breasts and attached
to the bed). Hips will be positioned in neutral exten-
sion and rotation, hip abduction in mid range and
knee in extension. The dynamometer will be held
perpendicular to the thigh above the lateral femoral
condyl of the leg being tested with one foot of the
tester against a wall for stability. Subjects will be
instructed to push with maximum effort. One prac-
tice trial will be carried out prior to testing. A four
second hip abduction isometric maximal contraction
will be recorded. Mean maximum force over 3 mea-
surements for each leg will be calculated [49].
2. Subjects will rest for five minutes after which a
Maximun Voluntary EMG Contraction (MVC) of the
non-hemiplegic gluteus maximus and gluteus medius
will be measured. The skin will be prepared for sur-
face EMG placement. Skin will be shaved over the
appropriate muscles and cleaned with alcohol. Sur-
face EMG electrodes (Kendall, Tyco/Healthcare) will
be placed onto the skin overlying these muscles fol-
lowing the “European Recommendations for Surface
Electromyography” (SENIAM) guidelines with a spa-
cing of 20 mm [50]. The ground electrode will be
placed on the clean shaven skin overlying the sacrum.
EMG is measured at a sampling rate of 2048 Hz with-
out filtering so that the signals are measured includ-
ing DC. The digitalised data will be high pass filtered
with a fourth order filter with a cut off frequency of
10 Hz and full wave rectified. To test gluteus maxi-
mus subjects will lie prone on an examination plinth.
With hip and knee extended manual resistance will
be given at the ankle joit in the opposite direction to
movement. Subjects will be asked to slowly increase
the force, reaching maximum effort after 3-5 sec,
hold it for 3 sec and relax over 3 sec. A rest for 1 min
will provided after which the test will be carried out
once more. The maximum value from both tests will
be used a s MVC.
To test gluteus medius, subjects will lie on the hemi-
plegic side. < the subject will beinstucted to lift leg side-
ways and manual resistance will be applied at the ankle
in the opposite direction to movement. Subjects will be
asked to slowly increase the force, reaching maximum
effort after 3-5 sec, hold it for 3 sec and relax over 3
sec. A rest for 1 min will provided after which the test
will be carried out once more. The maximum value
from both tests will be used a s MVC.
3. Electrodes will be removed from the non-hemiple-
gic side and will be applied with the same procedure
as described above to the hemiplegic muscles of glu-
teus maximus, gluteus medius, vastus lateralis, semi-
tendinosis, gastrocnemius and tibialis anterior.
Henna will be applied to ensure accurate replace-
ment at subsequent sessions.
4. The electrogomiometer, foot switches and SwayS-
tar instrumentation will also be fitted. A biaxial elec-
trogoniometer will be placed over the anterior
hemiplegic hip joint line, proximal arm in line with
the anterior superior iliac spines, distal in line with
the axis of the femur. Foot switches will be placed
under the calcaneus and the third distal phalange of
each foot to measure “initial contact” and “foot off”
simultaneously with the EMG. SwayStar will be
strapped to the patient’s waist.
5. Patients will complete the “Timed up and go test”.
Time taken will be recorded, EMG activity, dynamic
balance and hip kinematics will be collected and
video recordings will be taken.
6. Subjects will then rest for five minutes after which
they will walk for twelve gait cycles three times. Sub-
jects will rest for five minutes between each set of
twelve gait cycles. Data collected during the first two
and last two gait cycles will be excluded. Data from
the three sets of eight remaining gait cycles will be
used to calculate mean values.
7. Patients will rest for ten minutes and then walk
over a set of four low (24 cm high) barriers placed 1
m apart.
8. Measurement equipment will be removed, patients
will rest for 20 min with a drink after which the SIS
will be completed.
Analysis
Hemiplegic peak EMG values of gluteus maximus and
medius will be compared as a percentage of the maxi-
mum voluntary contraction peak EMG value of the
same muscles of the unaffected leg.
Activation patterns of gluteus maximus, gluteus med-
ius, vastus lateralis, semitendinosis, gastrocnemius and
tibialis anterior will be assessed at baseline and at subse-
quent data collection points. On and off times for each
muscle during each stride will be calculated. An ampli-
tude of two standard deviations higher that the resting
(reference) amplitude will be considered “on” activity.
All detected on- and off- times will be normalised in
time using the stride time from the related heel strike
measured by a foot switch. SEMG will be rectified and
filtered with a high pass fourth order filter with a cut off
of 10 Hz and plotted with the timing information along
the x-axis. Total burst duration (gait cycle time minus
off time) and median on and off times in percentage of
the gait cycle will be calculated for each subject for each
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muscle. Activation patterns will be compared to estab-
lished normal patterns.
For kinematic measures mean hip range of movement
during 1 gait cycle in the frontal plane (ab/aduction)
and in the sagittal plane (flex/ext) will be measured for
the intervention groups and compared with normal
values for matched controls.
Balance control will be assessed with four measure-
ments consisting of trunk pitch (forwards-backwards)
angular displacement and velocity and roll (side to side)
angular displacement and velocity. Measurements will
be taken during all tasks. The fibreoptic gyroscopes
(SwayStar) will be attached via a belt to the subjects so
that the sensors are at the level L2/3. The sensors will
be attached to a computer via a Bluetooth communica-
tion, which will sample the velocity signals every 100 ms
and numerically integrate the velocity signals to yield
angular displacement. The mean will be taken from the
maximum values of the two angular displacement mea-
sures and the two angular velocities for the cane and
TheraTogs intervention groups. The Sway Star has been
has been used to assess static and dynamic balance in
healthy individuals of differing ages [44,51] and for insti-
tutionalised older individuals [45]. The means obtained
for the intervention groups post treatment will therefore
be compared to baseline values and to established nor-
mal values.
Accelerometer activity monitoring
The accelerometer (Aipermon® GmbH, Germany) will
be attached to the patient’s belt and positioned above
the left hip. Patients will wear the device during waking
hours during intervention time. The accelerometer will
be attached after dressing in the morning and only
taken off for showering, bathing and sleeping. In the sta-
tistical analysis a day starts at 24.00 o’clock and ends at
23.59 o’clock the same day. Mean activity per day will
be calculated. All device settings (date, time, weight, age
and gender) are pre-programmed for each patient upon
receiving it and the device is switched on throughout
the entire measurement period to keep patient handling
of the accelerometer to a minimum. Upon completion
of the intervention, the data is copied onto a PC, and its
contents are viewed via ActiCoach MPAT2Viewer,
Aipermon®. Wearing-time include min/day spent pas-
sively (PAS: sitting), actively (ACT: movement, but not
walking), walking (WLK: 0-5 km/h)) and fast walking
(FWLK: > 5 km/h). These are computed and analyzed.
Walking speeds from 0 to 80 m/min are detected as
Walking and walking speeds from 83 to 115 m/min are
detected as Fast Walking. Speeds above 115 m/min are
considered Sportive at which point walking would turn
into jogging in most individuals. Non-wearing time is
indicated by the device as “resting mode”. Walking and
fast walking times are added to a total walking time
(TWT). Activity modes and accelerometer detection
accuracy have been extensively validated [46].
Blinding
All testing procedures will be carried out by dedicated
trained, blinded assessors. A further research assistant
will be responsible for data input. The data will be ana-
lysed by the main author.
Sample size and power calculation
In order to detect a clinically significant difference in
the primary outcome measure of “Timed up and go” of
10 sec (from a likely range of 10-40 sec), with a prob-
ability of 80% at a two sided 5% significance level a total
of 116 patients (58 per group) must enter the study.
This calculation was performed assuming a SD of the
timed up and go of 19 sec [52]. Since there are indica-
tions that the distributions of the primary endpoint vari-
able is skewed, the use of a nonparametric test should
increase the actual power. To allow for drop-outs 60
participants per intervention will be recruited.
Randomization and allocation concealment
Subjects will be randomised into cane or TheraTogs
group using a computer generated randomisation pro-
gramme. Allocation will be concealed with group alloca-
tion contained in centrally held sealed envelopes at
Maastricht University.
Statistical methods
The primary analysis will be performed in an intention-
to-treat fashion, i.e. all subjects who where randomised
and have at least a Timed Up and Go assessment before
start of therapy will be included in all analyses. In the
primary analysis, missing values will be replaced by the
last available value. If no value under or after treatment
is available, the value measured before start of therapy
will be used.
The primary analysis will be performed on the Timed
Up and Go after 5 weeks of therapy. A nonparametric two
sample Wilcoxon-Mann-Whitney test will be performed.
Significance levels will be 5%. As robustness analyses, an
analysis of covariance will be performed with the value
before start of therapy as covariate and centre and therapy
as factors. 95% CI’s will be calculated based on this analy-
sis. Descriptive statistics for all data will be presented. For
continuous data, this will include the change from pre-
therapy values. Pre-therapy values will be compared
between groups to identify relevant co-variables.
Discussion - implications of the hypothesis
Various forms of walking aids are commonly used in
post stroke rehabilitation although the long term effects
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have been sparsely researched. In order to ensure the
positive effect of these treatments and to enable evi-
dence based practice, these interventions should be
clinically researched.
Early walking is an important aim of stroke rehabilita-
tion for many reasons including the psychological well-
being of the patient, to prevent loss of cardiovascular fit-
ness or the development of secondary musculoskeletal
problems. This study questions whether canes are the
optimal walking aid to enable early independent walking
as their use inhibits rather than stimulates activity of the
hemiplegic musculature and reduces the use of auto-
matic balance responses contrary to the aims of rehabili-
tation. A possible alternative to cane use was recently
tested by the authors in whom the immediate effects of
TheraTogs were to significantly improve hip abductor
muscle activity compared to cane walking or walking
without walking aids [38].
The rate of recovery of all impairments after stroke is
greatest in the first few weeks and slows down after two
to three months. Kwakkel et al. discussed an early win-
dow during which rehabilitation has the most long term
impact [17]. The potential negative or positive effects of
walking aids may therefore be particularly significant in
this early stage. To our knowledge no studies have
investigated this question before. The results of this
study may have important clinical significance and
could be used in the development of guidelines for gait
rehabilitation following stroke.
Additional material
Additional file 1: Flow Chart.
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